Literature DB >> 8725868

Effect of long-term glycemic control on cognitive function.

N B Lincoln1, R M Faleiro, C Kelly, B A Kirk, W J Jeffcoate.   

Abstract

OBJECTIVE: To investigate the relationship between recurrent hypoglycemia and cognitive impairment in insulin-dependent diabetic patients. RESEARCH DESIGN AND METHODS: Seventy patients who were diagnosed as diabetic at age 18 years or older, were under 55 years old, and had no condition likely to affect cognitive abilities were recruited from a diabetic register. Patients were interviewed to obtain information on the frequency of major and minor hypoglycemia. Their cognitive abilities were assessed on tests of premorbid intelligence, current intelligence, reaction time, concentration, memory, and information processing.
RESULTS: There was a significant correlation between the apparent decline in intelligence, expressed as the discrepancy between the estimated premorbid and the actual performance intelligence quotient, and the frequency of major hypoglycemic attacks (rs = -0.30; P < 0.01). Comparison of patients with and without recurrent hypoglycemia showed few significant differences in cognitive ability.
CONCLUSIONS: Results support previous work that suggests that major hypoglycemic attacks have a significant effect on some aspects of cognitive function, but the clinical importance of this finding remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725868     DOI: 10.2337/diacare.19.6.656

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  15 in total

Review 1.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

2.  Severe hypoglycaemia and cognitive impairment in diabetes.

Authors:  I J Deary; B M Frier
Journal:  BMJ       Date:  1996-09-28

Review 3.  Current status of clinical and experimental researches on cognitive impairment in diabetes.

Authors:  Xiao-chun Liang; Sai-shan Guo; Nobuyoshi Hagino
Journal:  Chin J Integr Med       Date:  2006-03       Impact factor: 1.978

4.  Recurrent Hypoglycemia Exacerbates Cerebral Ischemic Damage in Diabetic Rats via Enhanced Post-Ischemic Mitochondrial Dysfunction.

Authors:  Vibha Shukla; Perry Fuchs; Allen Liu; Charles H Cohan; Chuanhui Dong; Clinton B Wright; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Transl Stroke Res       Date:  2018-03-22       Impact factor: 6.829

5.  Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited.

Authors:  B M Frier
Journal:  Diabetologia       Date:  2010-11-26       Impact factor: 10.122

6.  Moderate recurrent hypoglycemia during early development leads to persistent changes in affective behavior in the rat.

Authors:  Holly Moore; Tara K S Craft; Lisa M Grimaldi; Bruna Babic; Susan A Brunelli; Susan J Vannucci
Journal:  Brain Behav Immun       Date:  2009-11-26       Impact factor: 7.217

7.  Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain.

Authors:  O Heikkilä; N Lundbom; M Timonen; P-H Groop; S Heikkinen; S Mäkimattila
Journal:  Diabetologia       Date:  2008-12-19       Impact factor: 10.122

Review 8.  Mini-review: impact of recurrent hypoglycemia on cognitive and brain function.

Authors:  Ewan C McNay; Victoria E Cotero
Journal:  Physiol Behav       Date:  2010-01-22

9.  Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats.

Authors:  Remya Robinson; Amee Krishnakumar; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2009-01-09       Impact factor: 5.046

10.  Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction.

Authors:  Thomas Duning; Ingeborg van den Heuvel; Annabelle Dickmann; Thomas Volkert; Carola Wempe; Julia Reinholz; Hubertus Lohmann; Hendrik Freise; Björn Ellger
Journal:  Diabetes Care       Date:  2009-12-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.